BRAF and endometrium neoplasm: Accordingly, colorectal tumour BRAF V600E status, or colorectal/endometrial tumour MLH1 promoter methylation (that are rarely detected in Lynch Syndrome associated tumours [21,69]), are very informative for identifying probable non-causal variants among mismatch-repair-deficient tumours.